These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. BCG in carcinoma in situ and superficial bladder tumors. Lamm DL Prog Clin Biol Res; 1988; 269():497-510. PubMed ID: 3293069 [No Abstract] [Full Text] [Related]
5. T1G3 transitional cell carcinoma of the bladder: recurrence, progression and survival. McHugh LA; Griffiths TR BJU Int; 2004 Jul; 94(1):193. PubMed ID: 15217467 [No Abstract] [Full Text] [Related]
6. BCG vaccine in urinary bladder cancer. Brosman SA West J Med; 1991 Dec; 155(6):633. PubMed ID: 1812634 [No Abstract] [Full Text] [Related]
7. Follow-up of the effect of BCG vaccine treatment in bladder tumour patients. Kulcsár G; Nász I; Tenke P; Csata S Acta Microbiol Hung; 1993; 40(2):151-7. PubMed ID: 8184669 [TBL] [Abstract][Full Text] [Related]
8. Bladder cancer in 2014: From the genomic frontier to immunotherapeutics. Lenis AT; Chamie K Nat Rev Urol; 2015 Feb; 12(2):74-6. PubMed ID: 25558841 [No Abstract] [Full Text] [Related]
10. Treatment of superficial carcinoma of the bladder. Paulson DF Prog Clin Biol Res; 1984; 162B():193-209. PubMed ID: 6209720 [No Abstract] [Full Text] [Related]
11. Immunotherapy for the treatment of superficial and infiltrative bladder carcinoma. Cockett AT; Merguerian PA; di Sant'Agnese PA; Wheeless LL Prog Clin Biol Res; 1989; 303():455-62. PubMed ID: 2675003 [No Abstract] [Full Text] [Related]
12. [Review of the value of BCG maintenance therapy in superficial bladder tumours]. Peyromaure M; Zerbib M Prog Urol; 2004 Feb; 14(1):105-8. PubMed ID: 15098767 [TBL] [Abstract][Full Text] [Related]
13. [International Consensus Panel--treatment strategies for superficial bladder cancer]. Adler S; St Niclas M Aktuelle Urol; 2006 Sep; 37(5):320-3; discussion 322-3. PubMed ID: 17004179 [No Abstract] [Full Text] [Related]
14. HSP90 expression: a new predictive factor for BCG response in stage Ta-T1 grade 3 bladder tumours. Lebret T; Watson RW; Molinié V; Poulain JE; O'Neill A; Fitzpatrick JM; Botto H Eur Urol; 2007 Jan; 51(1):161-6; discussion 166-7. PubMed ID: 16828965 [TBL] [Abstract][Full Text] [Related]
15. [Treatment and follow-up of superficial bladder cancer]. Raitanen M Duodecim; 2002; 118(9):903-9. PubMed ID: 12238168 [No Abstract] [Full Text] [Related]
16. [Immunotherapy in superficial bladder carcinoma]. Ríos González E; Martínez-Piñeiro Lorenzo L; Martínez-Piñeiro Caramés JA; de la Peña Barthel JJ Arch Esp Urol; 2000 Dec; 53(10):879-92. PubMed ID: 11213392 [TBL] [Abstract][Full Text] [Related]